More than one-quarter of blood or marrow transplant survivors developed cutaneous malignant neoplasms, according to study results.Researchers identified several risk factors, including older age, ...
Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...
but only about one-quarter of cutaneous melanomas are discovered directly by physicians (Zalaudek, Ferrara, Argenziano, Ruocco, & Soyer, 2003). Established risk factors for malignant melanoma ...
The following is a summary of “Skin cancer risk in over 200.000 patients with haematologic malignancies in 30 years; a ...
Survivors of blood or marrow transplants (BMT) face a significantly higher risk of developing cutaneous malignant neoplasms, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and ...
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...
The trial is sponsored by Ellen Kim, MD, Director, Penn Cutaneous Lymphoma Program ... applied to skin lesions that is taken up by the malignant T-cells, and then activated by safe, visible ...
Background Previous studies on the associations between socioeconomic status (SES) and cutaneous malignant melanoma (CMM) failed to distinguish the effects of different SES factors under an individual ...
This personalised approach will hopefully culminate in better health outcomes for patients with malignant melanoma. Conceptualisation, HN and GB; writing—original draft preparation, HN; writing—review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback